Abeona Therapeutics Inc. Common Stock (ABEO) is a publicly traded Healthcare sector company. As of August 3, 2026, ABEO trades at $6.39 with a market cap of $365.91M and a P/E ratio of -4.14. ABEO moved +0.00% today. Year to date, ABEO is +23.94%; over the trailing twelve months it is +0.78%. Its 52-week range spans $3.93 to $7.54. Analyst consensus is strong buy with an average price target of $19.75. Rallies surfaces ABEO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for ABEO, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $6.39 |
| Market Cap | $365.91M |
| P/E Ratio | -4.14 |
| EPS | $-1.55 |
| Dividend Yield | 0.00% |
| 52-Week High | $7.54 |
| 52-Week Low | $3.93 |
| Volume | 48.39K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-63.73M |
| Gross Margin | 0.00% |
4 analysts cover ABEO: 0 strong buy, 4 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $19.75.